A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

A genetically modified herpes simplex virus, called RP1, has now been shown to destroy advanced melanoma tumors, even when ...

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a ...

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically ...

Genital Herpes Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current genital herpes marketed drugs ...

Modified Herpes Virus as a Weapon Against Skin Cancer? A new study suggests it might work—even for metastases deep within the ...

The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

A virus once known for causing cold sores could potentially give cancer patients a fighting chance.

Scientists in Spain and China discovered that HSV-1 begins rewriting the architecture of human genes just one hour after ...